Raynaud's disease: a new therapeutic approach with a 5-HT2 receptors blocker. - Suppr | 超能文献

Raynaud's disease: a new therapeutic approach with a 5-HT2 receptors blocker.

作者信息

Allegra C, Tonelli V, Bonifacio M, Mari A, Assogna G

出版信息

Boll Chim Farm. 1985 Oct;124(10):121S-124S.

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Raynaud's disease: a new therapeutic approach with a 5-HT2 receptors blocker.

Boll Chim Farm. 1985 Oct;124(10):121S-124S.

2

Ketanserin (5 HT2-antagonist) in secondary Raynaud's phenomenon.

J Cardiovasc Pharmacol. 1984 Sep-Oct;6(5):975-6. doi: 10.1097/00005344-198409000-00037.

3

Treatment of Raynaud's phenomenon with the 5-HT2-receptor antagonist ketanserin.使用5-羟色胺2受体拮抗剂酮色林治疗雷诺现象。

Br Med J (Clin Res Ed). 1982 Oct 16;285(6348):1069-71. doi: 10.1136/bmj.285.6348.1069.

4

Quantitative study of the effects of Ketanserin in patients with primary Raynaud's phenomenon. A randomized, double blind, placebo controlled investigation and an additional long term open trial.酮色林对原发性雷诺现象患者影响的定量研究。一项随机、双盲、安慰剂对照研究以及一项额外的长期开放试验。

Microcirc Endothelium Lymphatics. 1985;2(6):657-85.

5

Treatment of Raynaud's phenomenon with ketanserin in patients with connective tissue disorders.用酮色林治疗结缔组织病患者的雷诺现象。

Br Med J (Clin Res Ed). 1984 Sep 8;289(6445):577-9. doi: 10.1136/bmj.289.6445.577.

6

Treatment of Raynaud's phenomenon with ketanserin, a selective antagonist of the serotonin2 (5-HT2) receptor.用酮色林（一种5-羟色胺2（5-HT2）受体的选择性拮抗剂）治疗雷诺现象。

Arthritis Rheum. 1984 Feb;27(2):139-46. doi: 10.1002/art.1780270204.

7

Effect of ketanserin on Raynaud's phenomenon in progressive systemic sclerosis: a double-blind trial.酮色林对进行性系统性硬化症中雷诺现象的影响：一项双盲试验。

Drugs Exp Clin Res. 1985;11(9):659-63.

8

Selective antagonism of S2-serotonergic receptors relieves but does not prevent cold induced vasoconstriction in primary Raynaud's phenomenon.

J Rheumatol. 1986 Apr;13(2):337-40.

9

The effectiveness of ketanserin in patients with primary Raynaud's phenomenon. A randomized, double blind, placebo controlled study.酮色林治疗原发性雷诺现象患者的有效性。一项随机、双盲、安慰剂对照研究。

Int Angiol. 1987 Jul-Sep;6(3):313-22.

10

Effect of chronic ketanserin treatment on serotonin-induced platelet aggregation in patients with Raynaud's phenomenon.慢性酮色林治疗对雷诺现象患者血清素诱导的血小板聚集的影响。

Eur J Clin Pharmacol. 1990;39(3):289-90. doi: 10.1007/BF00315113.